NASDAQ: DSGNDesign Therapeutics Inc Stock Ownership - Who owns Design Therapeutics?
Insider buying vs selling
Have Design Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Heather A. Berger | Director | 2024-03-25 | 1,300 | $3.74 | $4.87kBuy |
| John P. Schmid | Director | 2024-03-25 | 17,809 | $3.74 | $66.61kBuy |
| John P. Schmid | Director | 2024-03-22 | 9,156 | $3.62 | $33.14kBuy |
| Rodney W. Lappe | Director | 2023-09-29 | 21,000 | $2.35 | $49.29kBuy |
| Deepa Prasad | Director | 2023-08-29 | 12,000 | $2.31 | $27.67kBuy |
| Arsani William | Director | 2023-08-29 | 1,960,000 | $2.44 | $4.78MBuy |
| Arsani William | Director | 2023-08-28 | 275,000 | $2.15 | $591.25kBuy |
DSGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DSGN insiders and whales buy or sell their stock.
DSGN Shareholders
What type of owners hold Design Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Simeon George | 21.51% | 12,152,952 | $45.70M | Insider |
| Arsani William | 12.51% | 7,065,002 | $26.56M | Insider |
| Sr One Capital Fund I Aggregator LP | 11.55% | 6,526,476 | $24.54M | Insider |
| Sr One Capital Management LP | 11.55% | 6,526,476 | $24.54M | Institution |
| Cormorant Asset Management LP | 9.05% | 5,114,844 | $19.23M | Insider |
| Logos Global Management LP | 8.91% | 5,032,501 | $18.92M | Institution |
| Quan Venture Fund Ii LP | 8.36% | 4,720,830 | $17.75M | Insider |
| Stella Xu | 7.33% | 4,139,950 | $15.57M | Insider |
| Blackrock Inc | 4.21% | 2,380,242 | $8.95M | Institution |
| Deepa Prasad | 3.26% | 1,841,079 | $6.92M | Insider |
DSGN vs Biotech Stocks
Design Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.